IMPLANT SITE CALCIFICATION

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting IMPLANT SITE CALCIFICATION:

# Drug Count
0 BACLOFEN 4
1 BACLOFEN INJECTION 3
2 APREMILAST 1
3 CALCIUM 1
4 CAPECITABINE 1
5 CINACALCET HYDROCHLORIDE 1
6 CLONAZEPAM 1
7 DOCUSATE CALCIUM 1
8 DOCUSATE SODIUM 1
9 DOCUSATE SODIUM 100MG 1
See all common drugs associated with IMPLANT SITE CALCIFICATION

IMPLANT SITE CALCIFICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACLOFEN INJECTION 3 0.0010
1 MARC GLASSMAN 1 0.0003
2 DOCUSATE SODIUM AND SENNOSIDES 1 0.0002
3 DOCUSATE CALCIUM 1 0.0002
4 DOCUSATE SODIUM SENNOSIDES 1 0.0002
5 LANTHANUM CARBONATE 1 0.0002
6 EPOETIN ALFA 1 0.0001
7 BACLOFEN 4 0.0000
8 IMATINIB MESYLATE 1 0.0000
9 CINACALCET HYDROCHLORIDE 1 0.0000
See all drugs enriched for association with IMPLANT SITE CALCIFICATION

IMPLANT SITE CALCIFICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid-ergic Agonist [EPC] 7 0.0001
1 Parathyroid Hormone Analog [EPC] 1 0.0000
2 Sulfonylurea [EPC] 1 0.0000
3 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
4 Calcium [EPC] 1 0.0000
5 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
6 Thiazide Diuretic [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
8 Progestin [EPC] 1 0.0000
9 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with IMPLANT SITE CALCIFICATION